Pierre Broqua
Co-FounderDr. Pierre Broqua, Ph.D., Co-Founded Inventiva S.A. in 2011 and served as Chief Scientific Officer of Inventiva S.A. since 2011 until 2025 and was its Deputy Chief Executive Officer since May 31, 2016 and served as its Director since May 31, 2016 until 2025. Dr. Broqua has experience in drug discovery and innovative research to Inventiva. Before co-founding Inventiva, he successfully managed numerous research programs leading to the discovery of highly innovative preclinical and clinical compounds, in particular during his tenure at Ferring Pharmaceuticals from 1997 to 2002 and Fournier Laboratories from 2002 to 2005, as Head of Neuroscience for Solvay Pharmaceuticals from 2007 to 2010 and finally as Head of Research for the Abbott Dijon R&D site. One of his most notable achievements was his co-discovery, while head of Pharmacology at Ferring Pharmaceuticals, of the GnRH antagonist Degarelix (now marketed under the brand name Firmagon). Dr. Broqua holds a Ph.D in Pharmacology from the University of Paris Descartes and has a master’s degree in Chemistry and Biochemistry from Université Pierre et Marie Curie, Paris.
Positions
- Company NameInventiva S.A.Stock CodeIVAPositionCo-FounderColleagues
- AOAndrew ObenshainChief Executive Officer
- MPMark PruzanskiIndependent Chairman
- JVJean VolatierExecutive VP Finance & Corporate Social Responsibility
- MZMartine ZimmermannExecutive VP of Regulatory Affairs & Quality Assurance and Head of Regulatory Affairs
- JAJason A. CampagnaPresident of Research & Development and Chief Medical Officer
- JJJean-Louis JunienChairman of Scientific Advisory Board
- HCHeinz Christoph MaeusliIndependent Director
- GAG. Andre TurenneIndependent Director
- CSCamilla SoenderbyIndependent Director
